Pathological gambling induced by dopamine agonists;Dopaminergika-induziertes Pathologisches Glücksspiel

Fortschritte der Neurologie Psychiatrie

Volumn 79, Issue 8, 2011, Pages 470-474

  Gahr, M ^a   Connemann, B J ^a   Schonfeldt Lecuona C J ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

cabergoline; impulse control disorder; prolactinoma; ropinirole

Indexed keywords

CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; ROPINIROLE;

ADULT; ARTICLE; CASE REPORT; GAME; HUMAN; INTERNET; MALE; MONEY; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PROLACTINOMA; RESTLESS LEGS SYNDROME;

ANTIPARKINSON AGENTS; DOPAMINE AGONISTS; ERGOLINES; GAMBLING; HUMANS; INDOLES; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTINOMA; RESTLESS LEGS SYNDROME;

EID: 79960868303     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0031-1281580     Document Type: Article

References (40)

1. Everitt B, Robbins T. Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nat Neurosci 2005 8 1481-1489 (Pubitemid 41573659)
2. Dalley J, Fryer T, Brichard L et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007 315 1267-1270 (Pubitemid 46364262)
3. Cools R. Role of dopamine in the motivational and cognitive control of behavior. Neuroscientist 2008 14 381-395 (Pubitemid 352010072)
4. Bergh C, Eklund T, Sodersten P et al. Altered dopamine function in pathological gambling. Psycholog Med 1997 27 473-475 (Pubitemid 27139979)
5. Cooper J. ICD-10 Classification of Mental and Behavioural Disorders with Glossary and Diagnostic Criteria for Research ICD-10:DCR-10. Edinburgh, London, Melbourne, New York, Tokyo 1994
6. Dodd M, Klos K, Bower J et al. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurolog 2005 62 1-5
7. Gallagher D, OSullivan S, Evans A et al. Pathological gambling in Parkinsons disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Movement Disord 2007 22 1757-1763 (Pubitemid 47597599)
8. Voon V, Thomsen T, Miyasaki J et al. Factors associated with dopaminergic drug-related pathological gambling in Parkisnon disease. Arch Neurolog 2007 64 212-216
9. Molina J, Sainz-Artiga M, Fraile A et al. Pathological gambling in Parkinsons disease: A behavioral manifestation of pharmacologic treatment? Movement Disord 2000 15 869-872
10. Driver-Dunckley E, Noble B, Hentz J et al. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 2007 30 249-255 (Pubitemid 47511504)
11. Tippmann-Peickert M, Park J, Boeve B et al. Pathological gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 2007 68 301-303 (Pubitemid 46148346)
12. Kolla B, Mansukhani M, Barraza R et al. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling. Psychosomatics 2010 51 271-273
13. McElroy S, Philips K, Keck P. Obsessive compulsive spectrum disorder. JClin Psychiatr 1994 55 (Suppl 19) 33-51
14. McElroy S, Hudson J, Philips K et al. Clinical and theoretical implications of a possible link between obsessive-compulsive and impulse control disorders. Depression 1993 1 121-132
15. Petry N, Stinson F, Grant B. Comorbidity of DSM IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and related conditions. JClin Psychiatr 2005 66 564-574 (Pubitemid 40733697)
16. Petry N. Gambling and substance use disorder: current status and future directions. Am J Addict 2007 16 1-9 (Pubitemid 46341012)
17. Holden C. Behavioral addictions: do they exist? Science 2001 294 980-982
18. Grant J, Brewer A, Potenza M. The neurobiology of substance and behavioural addictions. CNS Spectr 2006 11 924-930
19. Potenza M. Should addictive disorders include non-substance-related conditions? Addiction 2006 101 (Suppl 1) 142-151 (Pubitemid 44199506)
20. Bühringer G, Kraus L, Sonntag D et al. Pathologisches Glücksspiel in Deutschland: Spiel- und Bevölkerungsrisiken. Sucht 2007 53 296-308
21. BZgA BfgA. Glücksspielverhalten und problematisches Glücksspielen in Deutschland 2007. Ergebnisse einer Reprä sentativbefragung. 2008
22. Buth S, Stöver H. Glücksspielteilnahme und Glü cksspielprobleme in Deutschland: Ergebnisse einer bundesweiten Repräsentativbefragung. Suchttherapie 2008 9 3-11
23. Evans A, Strafella A, Weintraub D et al. Impulsive and compulsive behaviors in Parkinsons disease. Mov Disord 2009 24 1561-1570
24. Kim S, Grant J. Personality dimensions in pathological gambling disorder and obsessive-compulsive disorder. Psychiatry Research 2001 104 205-212 (Pubitemid 33135501)
25. Nordin C, Nylander P O. Temperament and character in pathological gambling. JGambl Stud 2007 23 113-120
26. Breen R, Zuckermann M. Chasing in gambling behavior: personality and cognitive determinants. JPersonality Individual Differences 1999 27 1097-1111
27. Fiorillo C, Tobler P, Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science 2003 299 1898-1902 (Pubitemid 36356659)
28. Evans A, Pavese N, Lawrence A et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 2006 59 852-858 (Pubitemid 43673163)
29. Reuter J, Raedler T, Rose M et al. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005 8 147-148 (Pubitemid 40194043)
30. Knutson B, Gibbs S. Linking nucleus accumbens dopamine and blood oxygenation. Psychopharamcol 2007 191 813-822 (Pubitemid 46355904)
31. Potenza M, Leung H C., Blumberg H et al. An fMRI Stroop Tasl Study of Ventromedial Prefrontal Cortical Function in Pathological Gamblers. Am J Psychiatry 2003 160 1990-1994 (Pubitemid 39619636)
32. Weintraub D, Siderow A, Potenza M et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurolog 2006 63 969-973 (Pubitemid 44036299)
33. Johnson P, Madden G, Brewer A et al. Effects of acute pramipexole on preference for gambling-like schedules of reinforcements in rats. Psychopharmacol 2011 213 11-18
34. Madden G, Johnson P, Brewer A et al. Effects of pramipexole on impulsive choice in male wistar rats. Exp Clin Psychopharmacology 2010 18 267-276
35. Riba J, Kraemer U, Heldmann M et al. Dopamine agonist increase risk taking but blunts reward-related brain activity. Plos One 2008;e2479.
36. Augustijn P, Parra J, Wouters C et al. Ring chromosome 20 epilepsy syndrome in children: electroclinical features. Neurology 2001 57 1108-1111 (Pubitemid 32880215)
37. Edwards I, Aronson J. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000 356 1255-1259
38. Naranjo C, Busto U, Sellers E et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981 30 239-245 (Pubitemid 12149145)
39. Davie M. Pathological gambling associated with cabergoline. JNeuropsychiatry Clin Neurosci 2007 19 473-474
40. Falhammar H, Yarker J. Pathological gambling and hypersexuality in cabergoline-treated prolactinoma. MJA 2009 190 97